Tag:

COVID-19

Health

Nearly 70 weeks after infection, long COVID patients show no detectable inflammation in blood tests

by Chief Editor
written by Chief Editor

Long COVID’s Shifting Landscape: What Does the Lack of Detectable Inflammation Mean for the Future?

Nearly a year and a half after initial infection, a new study published in Scientific Reports is challenging long-held assumptions about the biological underpinnings of long COVID. Researchers found no detectable systemic inflammation or neuronal damage in blood samples from individuals experiencing persistent symptoms. This finding, while surprising, doesn’t signal the end of the long COVID story – but rather a potential shift in how we understand and treat this complex condition.

The Evolving Understanding of Long COVID Prevalence

Since 2020, the estimated global prevalence of long COVID has surged, climbing from 60 million to 400 million. While some early observations suggested symptoms remained static over time, more recent data indicates a trend towards lessening severity in some patients. But, the core mechanisms driving the chronic phase of the illness remain elusive. Is long COVID a post-infectious syndrome akin to others where symptoms linger without ongoing organ damage? Or does it involve reactivated viral reservoirs or persistent, yet subtle, organ dysfunction?

What the New Study Reveals – and Doesn’t Reveal

The Norwegian hospital-based study, conducted between January 2022 and April 2024, meticulously compared individuals with long COVID to those who had fully recovered from SARS-CoV-2 infection. Participants were carefully selected to exclude those with pre-existing inflammatory conditions that could confound the results. Researchers analyzed a range of biomarkers, including inflammatory cytokines and indicators of neuronal damage. The key finding? No significant differences were observed in these markers between the two groups.

Specifically, levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) were not significantly different between long COVID patients and recovered controls. Even after accounting for potential confounding factors, the results remained consistent. This suggests that, at least in this cohort and at this stage of the illness (69 weeks post-infection), overt immune activation or neuronal injury isn’t readily detectable in the bloodstream.

Why the Discrepancy? The Role of Timing and Patient Selection

The study’s findings contrast with earlier research that often reported elevated inflammatory markers in long COVID patients. Researchers suggest this discrepancy may be due to differences in the timing of assessments. Earlier studies were often conducted within months of initial infection, potentially capturing ongoing inflammation during the acute recovery phase. The longer follow-up period in this study may have allowed sufficient time for inflammation to resolve.

the careful patient selection in this study – excluding individuals with pre-existing inflammatory conditions – is crucial. Prior research may have inadvertently included individuals whose symptoms were attributable to underlying conditions rather than long COVID itself.

Future Research Directions: Beyond Inflammation

The absence of detectable inflammation doesn’t mean long COVID is “all in the head.” It simply suggests that the mechanisms driving the condition are more nuanced than previously thought. Future research will likely focus on several key areas:

  • Microclots and Endothelial Dysfunction: Emerging evidence points to the role of microclots – tiny blood clots – and damage to the endothelium (the lining of blood vessels) in long COVID. These issues may not be readily detectable through standard inflammatory markers.
  • Gut Microbiome Imbalance: Studies are increasingly exploring the link between gut microbiome dysbiosis and long COVID symptoms. Alterations in gut bacteria can influence immune function and inflammation, even in the absence of systemic inflammation.
  • Autonomic Nervous System Dysfunction: Many long COVID patients experience symptoms like fatigue, brain fog, and postural orthostatic tachycardia syndrome (POTS), which are often associated with autonomic nervous system dysfunction.
  • Residual Viral Reservoirs: While not definitively proven, the possibility of persistent viral reservoirs in certain tissues remains a topic of investigation.

The study authors acknowledge limitations, including a relatively small sample size and the use of blood-based biomarkers without corresponding cerebrospinal fluid or neuroimaging data. Larger, more comprehensive studies are needed to confirm these findings and explore these alternative mechanisms.

Pro Tip:

If you’re experiencing long COVID symptoms, advocate for a thorough evaluation that considers a broad range of potential contributing factors, not just inflammation. Discuss your concerns with your healthcare provider and explore options for specialized care.

Did you realize?

Women are disproportionately affected by long COVID, and research suggests sex-specific differences in the presentation and underlying mechanisms of the condition.

FAQ: Long COVID and Inflammation

  • Does this study mean long COVID isn’t real? No. It means the biological mechanisms driving long COVID are likely more complex than initially thought and may not always involve detectable systemic inflammation.
  • What should I do if I have long COVID symptoms? Seek medical evaluation and discuss potential treatment options with your healthcare provider.
  • Are there any treatments for long COVID? Currently, treatment focuses on managing individual symptoms. Research is ongoing to develop targeted therapies.
  • Is long COVID a chronic condition? The long-term trajectory of long COVID is still being studied. Some individuals experience symptom resolution over time, while others continue to struggle with persistent symptoms.

The evolving understanding of long COVID underscores the importance of continued research and a holistic approach to patient care. While the absence of detectable inflammation is a significant finding, it’s just one piece of the puzzle. By exploring alternative mechanisms and tailoring treatments to individual needs, One can move closer to providing effective relief for those living with this challenging condition.

Aim for to learn more about long COVID? Explore our other articles on post-viral syndromes and chronic fatigue.

0 comments
0 FacebookTwitterPinterestEmail
Health

Mushroom-derived supplement may be the key to longer vaccine protection and fewer side effects, UCSD study finds | News

by Chief Editor
written by Chief Editor

Mushroom Power: Could Fungi Be the Future of Vaccine Effectiveness?

Researchers at the University of California San Diego School of Medicine have uncovered a potentially groundbreaking link between medicinal mushrooms and improved vaccine response. A recent study, published in BMC Immunology on March 3, 2026, suggests a natural fungal supplement could be a game-changer in how we approach vaccination, boosting immunity whereas minimizing those dreaded post-shot side effects.

The Trade-Off in Vaccinology

For years, scientists have grappled with a central challenge in vaccine development: how to maximize the body’s immune response without causing significant discomfort. Traditional “immune adjuncts”—often synthetic compounds—can effectively enhance immunity, but frequently come with a price: fever, chills, and muscle aches that contribute to vaccine hesitancy. This new research explores a gentler, natural alternative.

Introducing FoTv: A Fungal Solution

The UCSD team focused on a supplement called “FoTv,” derived from the mycelium—the root-like network—of two specific fungi: Fomitopsis officinalis and Trametes versicolor (commonly known as Turkey Tail). Participants in the randomized, double-blind clinical trial began taking FoTv on the same day as their COVID-19 vaccination, continuing for four days.

Remarkable Results for the “COVID-Naïve”

The most compelling findings emerged from participants who were previously unexposed to COVID-19. This group experienced a significant reduction in common vaccine side effects, including fatigue and muscle aches. Even more remarkably, their antibody levels didn’t just peak and decline as typically observed; they continued to increase throughout the six-month study period.

“In this group, we saw a significant decrease in vaccine side effects while, remarkably, antibody levels continued to increase up to the six-month mark,” explained Dr. Gordon Saxe, the study’s principal investigator and a professor at UCSD School of Medicine.

Beyond COVID-19: Pandemic Preparedness and the Future of Immunity

The implications of this research extend far beyond the current COVID-19 landscape. Researchers believe this approach could be a scalable tool for future outbreaks, including potential threats like avian influenza (H5N1). The standardized, medical-grade methods used to grow fungal mycelium make it a potentially readily available resource.

Interestingly, the biological basis for this interaction may be deeply rooted in our evolutionary history. Humans and fungi share a common ancestor, and human immune cells possess receptors specifically designed to bind with compounds found in fungi.

“With emerging infectious threats such as H5N1 on the horizon, we require affordable and rapidly scalable tools,” Dr. Saxe stated. “This study shows that a carefully tested natural immune modulator may help support that goal.”

The Rise of Natural Immune Modulators

This study is part of a growing trend toward exploring natural compounds for immune support. While synthetic immune adjuncts have long been the standard, the potential for gentler, more sustainable solutions is gaining traction. The rigorous testing applied to FoTv – a randomized, double-blind, placebo-controlled clinical trial – sets a new standard for evaluating natural products in this field.

Did you know? Humans share more genetic similarities with fungi than with plants!

FAQ

Q: What is FoTv?
A: FoTv is a four-day oral supplement made from the mycelium of Fomitopsis officinalis and Trametes versicolor (Turkey Tail) mushrooms.

Q: Who benefited most from the supplement in the study?
A: Participants who had never been exposed to COVID-19 (“COVID-naïve”) experienced the most significant benefits, including fewer side effects and sustained antibody levels.

Q: Is this supplement currently available to the public?
A: The study results are recent, and further research is needed. The supplement is not yet widely available.

Q: Could this approach work with other vaccines?
A: Researchers believe the principles behind FoTv could be applied to other vaccines, potentially improving their effectiveness and reducing side effects.

Pro Tip: Maintaining a healthy lifestyle, including a balanced diet and regular exercise, is crucial for optimal immune function, regardless of vaccination status.

Further research is planned to confirm these findings and fully understand the mechanisms by which these fungal compounds interact with the human immune system. This study represents a promising step toward a future where vaccines are not only effective but also more tolerable and accessible to all.

What are your thoughts on the potential of natural supplements to enhance vaccine effectiveness? Share your comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Global breast cancer burden rising fastest in low-income countries

by Chief Editor
written by Chief Editor

Breast Cancer Cases Projected to Surge Globally: A Looming Health Crisis

Despite advancements in treatment, a new analysis from the Global Burden of Disease Study Breast Cancer Collaborators paints a concerning picture: global breast cancer cases are predicted to increase by a third, rising from 2.3 million in 2023 to over 3.5 million in 2050. Yearly deaths are also projected to climb significantly, increasing by 44% from approximately 764,000 to 1.4 million.

Shifting Burden: From High-Income to Low- and Middle-Income Countries

Although high-income countries (HICs) currently experience the highest rates of new breast cancer cases, the most rapid growth is occurring in low-income countries (LICs). This shift is attributed to factors like lifestyle changes and demographic shifts, coupled with health systems that are often ill-equipped to handle the increasing demand. These countries frequently face shortages of essential resources, including radiotherapy machines, chemotherapy drugs, and pathology labs.

Disparities in Survival Rates

Age-standardized death rates from breast cancer have fallen in HICs, decreasing by 30% between 1990 and 2023. But, in LICs, these rates have nearly doubled over the same period, highlighting significant disparities in timely diagnosis and access to quality treatment. This means women in LICs are facing a growing risk of succumbing to the disease.

The Impact of Modifiable Risk Factors

The study reveals that over a quarter of healthy years lost due to breast cancer could be prevented by adopting a healthier lifestyle. Key modifiable risk factors include avoiding smoking, maintaining sufficient physical activity, reducing red meat consumption, and achieving a healthy weight. High red meat consumption has the biggest impact, linked to nearly 11% of all healthy life lost.

Progress and Remaining Challenges

While progress has been made in reducing the burden linked to high alcohol use and tobacco consumption, other risk factors haven’t shown the same improvement. This suggests a need for more targeted public health interventions.

Rising Cases in Pre-Menopausal Women

Globally, most new breast cancer cases are diagnosed in women aged 55 or older. However, rates of new cases have risen in women aged 20-54 years since 1990, indicating a potential shift in age patterns and the influence of varying risk factors between pre- and post-menopausal women.

The Role of Early Detection and Comprehensive Care

Closing the care gap is crucial to improving outcomes. Ensuring fair access to care in low-resource settings, investing in innovative therapies, and demonstrating strong political will are essential steps. Reducing the cost of breast cancer therapies and including breast cancer care in universal health coverage are also vital.

The Need for Improved Surveillance Systems

The study acknowledges limitations due to a lack of high-quality cancer registry data, particularly in countries with limited resources. Increased investment in cancer surveillance systems is therefore critical for accurate monitoring and informed decision-making.

What Can Be Done?

Co-senior author Dr. Lisa Force emphasizes the need for collaborative efforts to ensure well-functioning health systems capable of early diagnosis and comprehensive treatment in all countries.

FAQ

Q: What is the Global Burden of Disease Study?
A: It’s a comprehensive assessment of disease trends, burden, and risk factors globally, regionally, and nationally.

Q: Which risk factors have the biggest impact on breast cancer?
A: High red meat consumption, tobacco use, high blood sugar, and high body mass index are among the most significant modifiable risk factors.

Q: Is breast cancer more common in certain countries?
A: While rates are currently highest in high-income countries, the fastest growth is occurring in low-income countries.

Q: What can individuals do to reduce their risk?
A: Maintaining a healthy lifestyle, including not smoking, getting sufficient physical activity, lowering red meat consumption, and having a healthy weight, can significantly reduce risk.

Did you know? Maintaining a healthy lifestyle may prevent over a quarter of healthy years lost to illness and premature death due to breast cancer worldwide.

Pro Tip: Early detection is key. Be aware of your body and report any changes to your healthcare provider.

Learn more about cancer prevention and early detection by exploring resources from the National Cancer Institute.

What are your thoughts on these findings? Share your comments below and let’s discuss how we can work towards a future with reduced breast cancer rates.

0 comments
0 FacebookTwitterPinterestEmail
Health

‘My partner lives in terror of Covid and it has shrunk our lives’ – The Irish Times

by Chief Editor
written by Chief Editor

The Lingering Shadow of Pandemic Anxiety: When Safety Becomes a Prison

The COVID-19 pandemic fundamentally altered our relationship with risk. While public health measures have eased, for many, the anxieties sparked during those uncertain times continue to exert a powerful influence on daily life. A recent letter to an advice columnist highlights a particularly challenging dynamic: a relationship strained to the breaking point by disproportionate fear and avoidance behaviors, exacerbated by underlying mental health conditions like anxiety, PTSD, and ADHD.

The Rise of “Post-Pandemic Stress” and its Impact on Relationships

The case described mirrors a growing trend. While not formally recognized as a clinical diagnosis, the term “post-pandemic stress” is increasingly used to describe the persistent anxiety and behavioral changes experienced by individuals long after the initial crisis has subsided. This can manifest as heightened vigilance, avoidance of public spaces, and an insistence on strict safety protocols. Research indicates that the pandemic significantly worsened symptoms in individuals with pre-existing mental health conditions, including ADHD, PTSD, and depression.

The core issue isn’t simply caution, but a level of risk avoidance that eclipses normal life. As the advice columnist points out, there’s a crucial difference between precautions that allow life to continue and those that replace it entirely. This can lead to isolation, strained relationships, and a diminished quality of life, not only for the anxious individual but also for their loved ones.

Underlying Conditions: ADHD, PTSD, and the Amplification of Fear

The interplay of ADHD, PTSD, and anxiety is particularly relevant. Individuals with ADHD may struggle with impulse control and emotional regulation, making it harder to navigate uncertainty and manage fear. PTSD, often stemming from traumatic experiences, can lead to hypervigilance and avoidance behaviors. The pandemic itself served as a collective trauma, potentially triggering or exacerbating PTSD symptoms in many.

The advice columnist notes the importance of recognizing that the system described is driven by internal fear, not necessarily expert guidance. Without professional mental health support, anxieties can escalate, and the baseline for “safe enough” continually shifts. This creates a dynamic where accommodation doesn’t reduce fear, but solidifies it.

The Burden of Sole Support and the Need for Professional Help

A dangerous pattern emerges when one partner becomes solely responsible for the other’s emotional regulation and sense of safety. The letter writer’s fear of being the only stabilizing force in their partner’s life is understandable, but ultimately unsustainable. As the columnist emphasizes, one adult cannot indefinitely carry the weight of another’s wellbeing.

Seeking professional help is paramount. This includes medical guidance on realistic risk assessment, therapy for anxiety and trauma, and potentially couples counseling to explore mutually acceptable compromises. Although, willingness to engage in these interventions is crucial. Without it, the cycle of fear and avoidance is likely to continue.

Navigating Incompatibility: When Love Isn’t Enough

Sometimes, despite genuine care and effort, relationships become incompatible. When one partner prioritizes a highly risk-averse lifestyle while the other craves social connection, shared experiences, and the freedom to pursue their dreams, a fundamental conflict arises. The advice columnist rightly points out that neither partner is morally wrong, but their lived realities are fundamentally different.

Leaving a relationship is never easy, but it may be necessary to protect one’s own mental health, and future. Compassionate separation, involving clear communication, a respectful timeline, and support for the departing partner, can mitigate the pain. However, the columnist stresses that compassion does not require sacrificing one’s own wellbeing.

Future Trends: Long-Term Mental Health Impacts and the Search for Balance

The long-term mental health consequences of the pandemic are still unfolding. We can anticipate a continued need for mental health services, particularly for individuals with pre-existing conditions. There will likely be increased focus on developing effective therapies for “post-pandemic stress” and addressing the complex interplay of trauma, anxiety, and avoidance behaviors.

the pandemic has highlighted the importance of social connection and community. As we move forward, finding ways to rebuild trust, foster resilience, and create safe spaces for social interaction will be crucial for individual and collective wellbeing.

FAQ

Q: Is it normal to still feel anxious about COVID-19?
A: Yes. The pandemic was a traumatic event, and it’s normal to experience lingering anxiety and heightened vigilance.

Q: What if my partner refuses to seek help?
A: You can’t force someone to get help, but you can set boundaries and prioritize your own wellbeing.

Q: How can I support a loved one with anxiety without sacrificing my own needs?
A: Encourage professional help, set clear boundaries, and prioritize self-care.

Q: Is “post-pandemic stress” a recognized medical diagnosis?
A: Not yet, but it’s a term increasingly used to describe the persistent mental health challenges following the pandemic.

Did you know? Studies indicate that individuals with lower household incomes experienced higher rates of probable PTSD during the pandemic. [3]

Pro Tip: If you’re struggling with anxiety or PTSD, reach out to a mental health professional. We find resources available to help you navigate these challenges.

Reader Question: “I’m feeling overwhelmed by the constant news cycle. How can I protect my mental health?”

Answer: Limit your exposure to news, practice mindfulness, and engage in activities that bring you joy and relaxation.

If you are struggling with similar issues, remember you are not alone. Explore resources available through mental health organizations and consider seeking professional guidance to navigate these complex challenges. Share your experiences in the comments below – let’s start a conversation.

0 comments
0 FacebookTwitterPinterestEmail
Health

Lingering brain inflammation found after mild COVID infection

by Chief Editor
written by Chief Editor

Long COVID’s Lingering Brain Effects: New Research Reveals Key Differences from the Flu

Even a mild case of COVID-19 or the flu can leave lasting impacts, but new research from Tulane University suggests the long-term consequences are strikingly different. The study, published in Frontiers in Immunology, sheds light on why some individuals experience debilitating symptoms weeks or months after initial infection, particularly neurological issues like brain fog, fatigue, and mood changes.

The Brain-Body Connection in Long-Term Illness

Researchers discovered that even as both COVID-19 and influenza can cause lasting lung damage, only SARS-CoV-2 infection resulted in persistent brain inflammation and small blood vessel injury in a mouse model, even after the virus was no longer detectable. This finding is critical to understanding the unique challenges posed by long COVID.

“Influenza and COVID-19 affect large populations worldwide and carry a significant public health toll, yet the mechanisms behind their long-term effects remain poorly understood,” explains Dr. Xuebin Qin, lead author and professor of microbiology and immunology at the Tulane National Biomedical Research Center.

Lung Damage: Similarities and Key Divergences

In the lungs, both viruses triggered a similar response: immune cells that didn’t fully deactivate and a buildup of collagen, leading to potential scarring. This can cause lingering shortness of breath. Although, a crucial difference emerged. After influenza, the lungs demonstrated a repair response, with cells working to rebuild airway lining. This repair mechanism was largely absent following COVID-19 infection, suggesting the virus may disrupt the natural healing process.

Brain Inflammation: The Hallmark of Long COVID

The most significant differences were observed in the brain. While neither virus was found *in* brain tissue, mice infected with COVID-19 exhibited persistent brain inflammation and tiny areas of bleeding weeks after infection. Gene expression analysis revealed ongoing inflammatory signaling and disruption of serotonin and dopamine regulation – systems vital for mood, cognition, and energy levels. These changes were minimal in influenza-infected animals.

“In both infections, we observed lasting lung injury,” Qin stated. “But long-term effects in the brain were unique to SARS-CoV-2. That distinction is critical to understanding long COVID.”

Future Trends and Implications

This research, supported by an American Heart Association award, points towards a future where long COVID is understood not just as a respiratory illness, but as a condition with significant neurological and vascular components. This understanding will be crucial for developing targeted therapies.

Several trends are emerging:

  • Personalized Medicine: Future treatments may be tailored to address the specific inflammatory and vascular changes observed in individual patients.
  • Early Intervention: Identifying biomarkers for brain inflammation early in the course of COVID-19 could allow for preventative interventions.
  • Vascular-Focused Therapies: Given the evidence of small blood vessel injury, therapies aimed at improving vascular function may prove beneficial.
  • Neurorehabilitation: For those experiencing persistent neurological symptoms, neurorehabilitation programs could help restore cognitive function and improve quality of life.

The study underscores the need for continued research into the long-term effects of COVID-19, particularly its impact on the brain and cardiovascular system.

FAQ

Q: What is “brain fog”?
A: Brain fog is a common symptom of long COVID, characterized by difficulty concentrating, memory problems, and mental fatigue.

Q: Is long COVID more serious than long-term effects from the flu?
A: This research suggests that long COVID can have unique neurological impacts not typically seen with the flu, potentially leading to more debilitating long-term symptoms.

Q: What can be done to prevent long COVID?
A: Vaccination remains the most effective way to reduce the risk of developing COVID-19 and potentially long COVID. Early treatment of infection may too help minimize long-term effects.

Did you recognize? The American Heart Association is actively funding research to understand the cardiovascular and cerebrovascular effects of long COVID.

Pro Tip: If you are experiencing persistent symptoms after a COVID-19 infection, consult with a healthcare professional for evaluation, and guidance.

Stay informed about the latest research on long COVID and its impact on your health. Explore additional resources from the Centers for Disease Control and Prevention and the American Heart Association.

0 comments
0 FacebookTwitterPinterestEmail
Health

Most flu deaths this century were recorded in 2025, ABS finds

by Chief Editor
written by Chief Editor

Flu Surpasses COVID-19 as Leading Respiratory Threat in Australia

Australia is experiencing a significant shift in the landscape of respiratory illnesses, with influenza now surpassing COVID-19 as the primary cause of death from acute respiratory infections. Data released on Tuesday, February 24, 2026, by the Australian Bureau of Statistics (ABS) reveals a concerning trend: 2025 saw the highest number of influenza-related deaths this century, totaling approximately 1,701.

A Dramatic Reversal: Flu Takes the Lead

For the past two years, COVID-19 dominated the statistics for respiratory-related fatalities. However, 2025 witnessed a sharp decline in COVID-19 deaths – falling by more than half to 2,161, compared to 5,108 in 2024. Simultaneously, influenza cases surged, exceeding COVID-19 related deaths from August 2025 onwards. Between August and December 2025, there were approximately 741 influenza deaths, compared to around 428 COVID-related deaths.

The Rise of Subclade K

Epidemiologist Catherine Bennett of Deakin University attributes the increased severity of the flu season to the emergence of a modern flu variant, H3N2 Subclade K. “The H factor, the Hemagglutinin protein, had a number of different mutations in it that we hadn’t seen before,” she explained. This mutation meant that existing vaccines and prior immunity were less effective, contributing to a prolonged outbreak extending into the summer months – an unusual occurrence.

Pro Tip: Staying up-to-date with annual flu vaccinations is crucial, even if the vaccine isn’t a perfect match for circulating strains. It can still significantly reduce the severity of illness and the risk of complications.

COVID-19: A Shift Towards Seasonality

While influenza is currently the more pressing concern, the ABS data indicates that COVID-19 is evolving into a more seasonal virus, with peaks typically occurring during the winter months. Professor Bennett noted that COVID-19 remains a significant threat during winter, responsible for more deaths than influenza during that period. However, for the first time, the summer months saw a considerably lower impact from COVID-19 in terms of fatalities.

RSV Remains a Factor

Respiratory Syncytial Virus (RSV) also contributed to the burden of acute respiratory infections, with approximately 582 deaths reported – about a hundred more than in 2024. This highlights the importance of considering multiple respiratory pathogens when assessing public health risks.

Vaccination Rates: A Critical Concern

A significant factor contributing to the severity of the 2025 flu season is low vaccination rates. Only around 60% of individuals over the age of 65 were vaccinated against the flu. Professor Bennett emphasized the vulnerability of this age group and the importance of increasing vaccination coverage to protect those most at risk of severe illness and death.

Looking Ahead: What Does This Mean for the Future?

The shift in dominance from COVID-19 to influenza underscores the dynamic nature of respiratory viruses. While COVID-19 hasn’t disappeared, its impact appears to be lessening, potentially settling into a seasonal pattern. However, the emergence of new influenza variants, like Subclade K, demonstrates the virus’s ability to evolve and evade immunity. This highlights the need for ongoing surveillance, vaccine development, and public health preparedness.

FAQ

Q: Is the flu vaccine effective against the new Subclade K variant?
A: While the vaccine may not be a perfect match, it can still reduce the severity of illness and the risk of complications.

Q: Is COVID-19 still a threat?
A: Yes, COVID-19 remains a significant respiratory virus, particularly during the winter months.

Q: What age group is most vulnerable to severe respiratory illness?
A: Individuals over the age of 70 are at the highest risk of severe illness and death from COVID-19, RSV, and influenza.

Q: Why were there more flu deaths in 2025 than in previous years?
A: The emergence of a new flu variant (H3N2 Subclade K) and lower vaccination rates contributed to the higher number of flu deaths in 2025.

Did you know? 2017 previously held the record for the highest number of influenza-related deaths this century, with approximately 1,656 deaths recorded.

Stay informed about respiratory health and take proactive steps to protect yourself and your community. Explore the Australian Department of Health website for the latest updates and recommendations.

0 comments
0 FacebookTwitterPinterestEmail
Health

Study identifies antiviral protein IFN-γ as a potential biomarker for Long COVID fatigue

by Chief Editor
written by Chief Editor

Unlocking Long COVID: The Role of IFN-γ and the Path to Personalized Treatment

Millions worldwide continue to grapple with the debilitating effects of Long COVID, placing a significant strain on healthcare systems. Now, a groundbreaking study led by the University of Cambridge has identified the antiviral protein interferon gamma (IFN-γ) as a potential biomarker for Long COVID fatigue, offering a crucial step towards understanding – and potentially treating – this complex condition.

The Persistent Immune Response: What the Research Reveals

SARS-CoV-2 infection normally triggers the production of IFN-γ as part of the body’s immune response. Typically, this production subsides once the infection clears. Still, researchers found that in some Long COVID patients, elevated levels of IFN-γ persisted for up to 31 months, correlating with ongoing symptoms like fatigue, muscle ache, and depression. This prolonged immune activation appears to be a key factor in the development and persistence of Long COVID.

The study, published in Science Advances, followed 111 COVID-confirmed patients and 55 experiencing severe Long COVID symptoms for an extended period. Analysis of blood samples revealed that white blood cells produced IFN-γ, a pro-inflammatory molecule, which remained elevated in Long COVID sufferers. Researchers pinpointed CD8+ T cells and CD14+ monocytes as the key immune cells driving this persistent IFN-γ production.

IFN-γ as a Biomarker: A New Avenue for Diagnosis

“We have found a potential mechanism underlying Long COVID which could represent a biomarker – that is, a tell-tale signature of the condition,” explains Dr. Benjamin Krishna, co-author of the study. “We hope that this could help to pave the way to develop therapies and give some patients a firm diagnosis.” Identifying IFN-γ levels could offer a more objective way to diagnose Long COVID, moving beyond reliance on self-reported symptoms.

Vaccination and Recovery: A Promising Connection

Interestingly, the research similarly suggests a link between vaccination and symptom improvement. Researchers observed a significant decrease in IFN-γ levels after vaccination in Long COVID patients whose symptoms resolved. This suggests vaccination may help clear persistent SARS-CoV-2, reducing the inflammatory response and alleviating symptoms. However, Dr. Krishna emphasizes the need for dedicated therapies, stating, “vaccination seems to be playing a significant role [in reducing Long COVID cases], but new cases are still cropping up.”

Beyond Microclotting: A More Complete Picture

While previous research has explored microclotting as a potential cause of Long COVID, this study suggests it may not be the sole or primary driver. The findings highlight the importance of immune dysregulation, specifically the persistent IFN-γ response, in understanding the condition’s complexities.

The Future of Long COVID Research: Personalized Medicine and Pandemic Preparedness

Classifying Long COVID Subtypes

The study proposes that IFN-γ levels could be used to classify Long COVID into subtypes, enabling more personalized treatment approaches. “It’s unlikely that all the different Long COVID symptoms are caused by the same thing,” Dr. Krishna notes. “We need to differentiate between people and tailor treatments.” This shift towards personalized medicine could dramatically improve outcomes for Long COVID patients.

Preparing for Future Pandemics

Understanding the mechanisms behind Long COVID isn’t just crucial for current patients; it’s vital for preparing for future coronavirus pandemics. As Dr. Krishna points out, “Understanding what causes Long COVID now could give us a crucial head start” in mitigating the long-term effects of future outbreaks.

Frequently Asked Questions

  • What is IFN-γ? IFN-γ is an antiviral protein produced by the immune system in response to infection.
  • Is Long COVID a real condition? Yes, research increasingly confirms Long COVID as a distinct and debilitating condition affecting millions.
  • Can vaccination help with Long COVID? The study suggests vaccination may reduce IFN-γ levels and improve symptoms in some patients.
  • Is microclotting the only cause of Long COVID? No, this study indicates that persistent immune activation, specifically IFN-γ production, plays a significant role.

Pro Tip: If you are experiencing persistent symptoms after a COVID-19 infection, consult with a healthcare professional to discuss potential Long COVID diagnosis and management options.

Want to learn more about the latest advancements in Long COVID research? Explore more articles on News-Medical.net.

0 comments
0 FacebookTwitterPinterestEmail
Health

Disordered lipid nanoparticles enhance RNA delivery efficiency

by Chief Editor
written by Chief Editor

The Messy Miracle: How Disorganized Nanoparticles Could Revolutionize Drug Delivery

The success of mRNA vaccines during the COVID-19 pandemic hinged on tiny, fatty bubbles called lipid nanoparticles (LNPs). These LNPs safely ferried genetic instructions into our cells, triggering an immune response. But scientists are discovering a surprising truth about these delivery vehicles: sometimes, less organization is more. New research suggests that LNPs with a slightly “messy” internal structure are actually more effective at releasing their therapeutic cargo inside cells.

Beyond COVID-19 Vaccines: The Expanding World of LNPs

LNPs aren’t just for vaccines. Researchers are actively exploring their potential to deliver treatments for a wide range of diseases, including cancer, genetic disorders, and other conditions. However, a significant hurdle has remained: the low efficiency of cargo delivery. Currently, only 1 to 5 percent of the RNA contained within LNPs actually makes it inside cells to exert its therapeutic effect.

“This low efficiency limits what One can do with LNPs as therapeutics,” explains Artu Breuer, a researcher at the University of Copenhagen. “For example, in cancer treatment where cells are dividing rapidly, if you deliver too little RNA, the cells outpace the therapy.”

Unveiling the Secrets Within: A New Measurement Technique

Traditionally, LNP research focused on maximizing the amount of medicine packed into each particle and ensuring its structural integrity. But a team led by Breuer developed a groundbreaking high-throughput method to analyze individual nanoparticles – up to a million at a time – revealing a previously unseen level of variation. This allowed them to identify two distinct types of LNPs: those with neatly organized internal structures and those with a more disordered, “amorphous” arrangement.

The results were counterintuitive. The disorganized LNPs proved to be significantly more effective at delivering their cargo. “Instead of assuming that every nanoparticle in a batch is the same, we found enormous variation,” Breuer said. “And we discovered two distinct subpopulations: organized particles where the cargo is neatly structured, and amorphous particles where it’s more disorganized. The surprise was that the messy ones actually work better inside cells.”

Why ‘Messy’ Works: A Matter of Charge and Release

The key lies in the interaction between positively charged lipids and negatively charged RNA within the nanoparticles. Highly organized LNPs, structured like layers of an onion, tightly bind these components, resisting release. In contrast, disorganized LNPs have some separation between the charges. When these particles enter a cell, changes in the internal environment cause the positive charges to repel each other, causing the nanoparticle to fall apart and release its medicinal payload.

“Think of it this way: in an organized nanoparticle, the positively charged lipids are tightly bound to the negatively charged RNA,” Breuer explained. “When the particle enters a cell, even though conditions change, those attractions hold everything together. But in a disorganized particle, there’s some separation between the charges. When conditions change inside the cell, the positive charges repel each other, and the particle falls apart—releasing the medicine.”

A Paradigm Shift in Nanoparticle Design

This discovery represents a potential paradigm shift in LNP design. Instead of striving for maximum cargo capacity and perfect organization, researchers may require to prioritize creating nanoparticles with a controlled degree of disorder. The goal isn’t to create empty nanoparticles, but to find the sweet spot where enough RNA is loaded while maintaining a structure that facilitates efficient release within cells.

This new single-nanoparticle measurement tool provides a powerful way to screen LNP formulations and pinpoint the structural features that truly impact delivery efficiency, potentially accelerating the development of more effective RNA-based medicines.

Future Trends and Implications

The implications of this research extend beyond simply improving existing LNP technology. It opens up new avenues for tailoring nanoparticles to specific cell types, and diseases. By manipulating the level of disorder within LNPs, scientists could potentially control the timing and location of drug release with unprecedented precision.

this research highlights the importance of single-particle analysis in nanotechnology. Traditional methods that rely on averaging properties across a large population of particles can mask crucial variations that impact performance. The ability to measure individual nanoparticles is becoming increasingly essential for understanding and optimizing these complex systems.

FAQ

Q: What are lipid nanoparticles (LNPs)?
A: LNPs are microscopic bubbles of fat used to deliver fragile RNA molecules into cells.

Q: Why are LNPs important?
A: They were crucial for the success of mRNA vaccines and are being explored for treatments for cancer, genetic diseases, and more.

Q: What does it mean that “messy” nanoparticles work better?
A: LNPs with a less organized internal structure release their cargo more effectively inside cells.

Q: Will this change how vaccines are made?
A: Potentially, yes. Researchers are now focusing on designing LNPs with a controlled degree of disorder to improve delivery efficiency.

Q: Where can I learn more about this research?
A: This research will be presented at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026.

Did you know? The efficiency of LNP delivery is a major bottleneck in RNA-based therapeutics. Improving this efficiency could unlock the full potential of this promising technology.

Pro Tip: Keep an eye on developments in single-particle analysis techniques. These tools are revolutionizing our understanding of nanotechnology and drug delivery.

What are your thoughts on this new research? Share your comments below and let’s discuss the future of drug delivery!

0 comments
0 FacebookTwitterPinterestEmail
Tech

Class of 2020: TikTok Trend Jokes About Lost Graduations

by Chief Editor
written by Chief Editor

The Class of 2020: How a Lost Graduation Became a Lasting TikTok Trend

The COVID-19 pandemic disrupted countless aspects of life, but for the Class of 2020, one loss stands out: the traditional graduation ceremony. Years later, the sting of that cancellation hasn’t faded, and it’s found a unique outlet on TikTok. What began as isolated expressions of disappointment has evolved into a widespread, self-deprecating meme, and a surprisingly resilient online community.

From Disappointment to Digital Punchline

Initially, TikTok users shared memories of their unconventional graduations – or lack thereof – using hashtags like #classof2020. Creators reminisced about “unprecedented” times and, in some cases, humorously “crashed” their siblings’ graduations as a symbolic gesture. The trend has recently resurfaced, merging with a broader TikTok format where users explain perspectives on common scenarios, like a half-full glass of water.

Instead of simply offering the “optimist” or “pessimist” viewpoint, TikTok creators now include the perspective of the Class of 2020. One creator lamented that their graduation “wasn’t even like a graduation, it was like a drive thru and you just grabbed your diploma.” This sentiment resonates widely, highlighting the feeling of a milestone diminished by circumstance.

Why the Trend Persists: Generational Trauma and Shared Experience

The enduring popularity of this trend speaks to a shared experience of loss and a unique form of generational trauma. The Class of 2020 entered adulthood during a period of immense uncertainty, and the cancelled graduation serves as a constant reminder of that disruption. TikTok provides a space to process these feelings collectively, using humor as a coping mechanism.

This isn’t simply about missing a ceremony; it’s about the symbolic loss of closure and the disruption of a significant rite of passage. The trend allows members of the Class of 2020 to acknowledge this loss, uncover solidarity with others who understand, and reclaim a sense of agency through shared storytelling.

Beyond Graduation: The Broader Implications for Online Identity

The Class of 2020’s experience on TikTok offers insights into how young people are navigating collective trauma and building online identities. The platform’s emphasis on short-form video and meme culture allows for quick, impactful expressions of emotion and shared experience. This trend demonstrates the power of social media to create communities around shared adversity.

The use of humor is particularly significant. By turning their disappointment into a punchline, the Class of 2020 is actively shaping the narrative around their experience, rather than passively accepting it. This proactive approach to storytelling is a hallmark of Gen Z’s online presence.

Future Trends: Milestone Moments and Digital Commemoration

Looking ahead, we can expect to see similar trends emerge around other disrupted milestone moments. The “COVID babies” who are now entering kindergarten may, in the future, develop their own unique ways of processing the unusual circumstances of their early childhood. The pandemic’s impact on social development and early education is only beginning to be understood, and social media will likely play a role in how these experiences are shared and processed.

Digital commemoration is also likely to become more prevalent. As technology evolves, we may see new forms of virtual ceremonies and online memorials that offer a sense of closure and community for those who have experienced loss or disruption. TikTok, and platforms like it, will likely be at the forefront of these innovations.

FAQ

Q: Why is the Class of 2020 still talking about their graduation?
A: The cancelled graduation represents a significant loss of a milestone event and a disruption to a key rite of passage, and TikTok provides a space to collectively process those feelings.

Q: Is this trend only popular with the Class of 2020?
A: While the trend primarily resonates with the Class of 2020, it has broader appeal as a relatable expression of disappointment and a commentary on shared experiences.

Q: What does this trend say about Gen Z’s use of social media?
A: It demonstrates Gen Z’s ability to use social media to build communities around shared adversity, process trauma, and shape narratives through humor and storytelling.

Did you know? The hashtag #classof2020 has billions of views on TikTok, demonstrating the widespread reach and impact of this trend.

Pro Tip: If you’re a member of the Class of 2020, consider sharing your own graduation story on TikTok using the hashtag #classof2020 to connect with others who understand.

What are your thoughts on the Class of 2020’s TikTok trend? Share your experiences and perspectives in the comments below! Explore more articles on generational trends and social media culture here. Subscribe to our newsletter for the latest insights and updates.

0 comments
0 FacebookTwitterPinterestEmail
Health

Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil

by Chief Editor
written by Chief Editor

The Future of Pandemic Preparedness: Lessons from COVID-19

The COVID-19 pandemic exposed critical vulnerabilities in global health security. A recent article in The Lancet, authored by Lurie, Keusch, and Dzau, underscores the urgent need for a standing, coordinated system and sustainable financing for global research and development (R&D). While rapid vaccine development – exemplified by the mRNA vaccines from Pfizer-BioNTech and inactivated vaccines like CoronaVac – demonstrated progress, significant gaps remain.

Accelerated R&D: A Pandemic Silver Lining

The speed with which vaccines and monoclonal antibodies were developed, trialed, and authorized during the COVID-19 pandemic was unprecedented. This acceleration built upon a decade of evolution in the R&D ecosystem. Yet, this progress doesn’t guarantee future success. Maintaining momentum requires addressing systemic weaknesses.

The Critical Need for Global Financing

A central theme emerging from the research is the paramount importance of a global financing system. The article highlights that without sustained investment, the gains made in pandemic response capabilities will be eroded. This isn’t simply about having funds available; it’s about ensuring those funds are strategically allocated to enabling sciences and product development.

Effective vaccine development, as seen with the Sinovac vaccine (Palacios et al., 2020) and the CoronaVac vaccine (Tanriover et al., 2021), requires substantial investment in clinical trials and manufacturing capacity. The rapid development of the BNT162b2 mRNA Covid-19 Vaccine (Polack et al., 2020) also demonstrates the power of focused funding.

Beyond Vaccines: A Holistic Approach to Preparedness

Preparedness extends beyond vaccine development. Effective surveillance systems, like the one implemented in Serrana, Brazil (Ferreira et al., 2022), are crucial for early detection and response. Understanding vaccine effectiveness – not just initial efficacy, but long-term protection against variants like Omicron (Andrews et al., 2022; Chemaitelly et al., 2023; Wu et al., 2023) – is also vital. This includes accounting for factors like prior infection and booster doses.

The Role of Innovative Trial Designs

Traditional clinical trial designs may not be optimal for pandemic response. Stepped-wedge cluster randomized trials, while complex, offer a pragmatic approach for evaluating interventions in real-world settings (Hemming et al., 2015; Kennedy-Shaffer & Lipsitch, 2020). These designs can be particularly useful when resources are limited or rapid answers are needed.

Addressing Real-World Effectiveness and Biases

Measuring real-world vaccine effectiveness is challenging. Studies must account for biases and confounding factors (Bodner et al., 2023). Understanding the interplay between direct and indirect effects – how vaccination protects both the vaccinated individual and the broader community (Eichner et al., 2017) – is essential for optimizing public health strategies. Concepts like herd immunity and hybrid immunity (Goldblatt, 2022) are constantly evolving and require ongoing research.

The Importance of Long-Term Monitoring

The pandemic highlighted the need for continuous monitoring of vaccine effectiveness over time. Studies evaluating the durability of protection offered by different vaccine platforms, including inactivated vaccines (Huang et al., 2023; Huang et al., 2022; Volpe et al., 2023), are crucial for informing booster strategies.

Frequently Asked Questions

  • What is a “standing” system for pandemic preparedness? It refers to a continuously funded and operational infrastructure, rather than one activated only during emergencies.
  • Why is global financing so important? Pandemics are global threats requiring coordinated international investment.
  • What are the challenges in measuring vaccine effectiveness? Real-world data can be affected by biases, variations in viral strains, and waning immunity.
  • What role do innovative trial designs play? They can provide faster and more practical answers during a pandemic.

Pro Tip: Stay informed about the latest research on vaccine effectiveness and emerging variants. Resources like the ECDC provide up-to-date information on vaccine performance across Europe (https://covid19-vaccines-efficacy.ecdc.europa.eu/).

What steps do you think are most critical for improving global pandemic preparedness? Share your thoughts in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts